GOTTLIEB, A. B.; ELEWSKI, B. E.; OKUN, M. M.; BAGEL, J.; POULIN, Y.; GU, Y.; GENG, Z.; WILLIAMS, D. A.; VALDECANTOS, W. C. Adalimumab for Nail Psoriasis: Efficacy and Safety from the Open-Label Extension of a Phase-3, Randomized, Placebo-Controlled Trial. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 1, n. 3.1, p. s97, 2017. DOI: 10.25251/skin.1.supp.96. Disponível em: https://www.jofskin.org/index.php/skin/article/view/75. Acesso em: 5 jul. 2022.